Who Just RaisedSan Francisco, CA · Health Care · Form D filed Sep 29, 2026
GT Biopharma, Inc. raised $7.8M
GT Biopharma, Inc. is a biotechnology company based in San Francisco, California. In a Form D filed with the SEC on September 29, 2026, it reported raising $7,750,000 from 9 investors as part of an offering of up to $38,958,054. The first sale in the offering took place on September 14, 2026.
- 11th Form D since 2014. Earlier new notices: May 28, 2025 · May 27, 2025 · Mar 7, 2025 · Jun 12, 2020 · Aug 17, 2018 · Feb 6, 2018 and more. All filings on EDGAR
- Still raising. $31.2M of the $39M offering was still unsold at filing.
$20.6M raised since 2020
5 Form D offerings, as reported to the SEC, the first in Jun 12, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 29, 2026 | $7.8M | $39M | 9 |
| May 28, 2025 | — | $20M | 2 |
| May 27, 2025 | $6M | $6M | 9 |
| Mar 7, 2025 | $1.3M | $1.3M | 6 |
| Jun 12, 2020 | $5.6M | Open | 18 |
Placement agent: H.C. Wainwright & Co., LLC
Lead score
33 out of 100
filed recently still raising budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- gtbiopharma.com
- Amount raised
- $7,750,000
- Offering size
- $38,958,054
- Investors so far
- 9
- First sale
- September 14, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- San Francisco, California
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $7,750,000 | $38,958,054 | 9 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 28, 2026 · Health Care funding in California · September 2026 funding report
Similar raises
Jaccard, Inc
San Francisco, CA · filed Oct 15First Form DStill raising
APR Labs Inc.
San Francisco, CA · filed Oct 14First Form DStill raising
Safi Analytics PBC
San Francisco, CA · filed Oct 142nd Form D since 2022Still raising
Contor, Inc.
San Francisco, CA · filed Oct 132nd Form D since 2026Still raising
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
Tempest Therapeutics, Inc.
Brisbane, CA · filed Oct 145th Form D since 2013
Renue Life Sciences, Inc.
San Carlos, CA · filed Oct 14First Form DStill raising